China Grand Wuhan General Pharmaceutical Research Institute - Product Pipeline Review - 2015

Nov, 2015   |   34  Pages   |   ISBN : GMDHC07805CDB   |   Global Markets Direct   |   Format : PDF

Summary

China Grand Wuhan General Pharmaceutical Research Institute - Product Pipeline Review - 2015, provides an overview of the China Grand Wuhan General Pharmaceutical Research Institutes pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of China Grand Wuhan General Pharmaceutical Research Institutes, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical t

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
China Grand Wuhan General Pharmaceutical Research Institute Snapshot 6
China Grand Wuhan General Pharmaceutical Research Institute Overview 6
Key Information 6
Key Facts 6
China Grand Wuhan General Pharmaceutical Research Institute - Research and Development Overview 7
Key Therapeutic Areas 7
China Grand Wuhan General Pharmaceutical Research Institute - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
China Grand Wuhan General Pharmaceutical Research Institute - Pipeline Products Glance 12
China Grand Wuhan General Pharmaceutical Research Institute - Late Stage Pipeline Products 12
Pre-Registration Products/Combination Treatment Modalities 12
China Grand Wuhan General Pharmaceutical Research Institute - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
China Grand Wuhan General Pharmaceutical Research Institute - Early Stage Pipeline Products 14
IND/CTA Filed Products/Combination Treatment Modalities 14
Preclinical Products/Combination Treatment Modalities 15
China Grand Wuhan General Pharmaceutical Research Institute - Drug Profiles 16
XY-0811QF2 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
XY-0817QA2 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
XY-0906AK2 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
XY-0915BF2 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
XY-1303LT2 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
XY-1807AN2 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
XY-0915LQ2 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
XY-1014KD2 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
XY-0902LB2 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
XY-0911AQ2 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
XY-0914FG2 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
XY-1004PS2 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
XY-1201MX2 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
XY-1207BL2 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
XY-0912ET2 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
XY-1107LN2 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
China Grand Wuhan General Pharmaceutical Research Institute - Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Appendix 33
Methodology 33
Coverage 33
Secondary Research 33
Primary Research 33
Expert Panel Validation 33
Contact Us 33
Disclaimer 34

List of Tables
China Grand Wuhan General Pharmaceutical Research Institute, Key Information 6
China Grand Wuhan General Pharmaceutical Research Institute, Key Facts 6
China Grand Wuhan General Pharmaceutical Research Institute - Pipeline by Indication, 2015 9
China Grand Wuhan General Pharmaceutical Research Institute - Pipeline by Stage of Development, 2015 10
China Grand Wuhan General Pharmaceutical Research Institute - Monotherapy Products in Pipeline, 2015 11
China Grand Wuhan General Pharmaceutical Research Institute - Pre-Registration, 2015 12
China Grand Wuhan General Pharmaceutical Research Institute - Phase II, 2015 13
China Grand Wuhan General Pharmaceutical Research Institute - IND/CTA Filed, 2015 14
China Grand Wuhan General Pharmaceutical Research Institute - Preclinical, 2015 15
China Grand Wuhan General Pharmaceutical Research Institute, Other Locations 32

List of Figures
China Grand Wuhan General Pharmaceutical Research Institute - Pipeline by Top 10 Indication, 2015 8
China Grand Wuhan General Pharmaceutical Research Institute - Pipeline by Stage of Development, 2015 10
China Grand Wuhan General Pharmaceutical Research Institute - Monotherapy Products in Pipeline, 2015 11

China Petrochemicals Report
The China Petrochemicals Report has been researched at source, and features BMI Research's market assessment and independent forecasts for key petrochemicals sub-sectors. The report also analyses the impact of regulatory changes, recent developments and the background macroeconomic outlook and featu
China Oil and Gas Report
BMI View: China's long-term crude oil and liquids output will remain on a firm downtrend as low oil prices slowdown exploration and render certain high-cost mature and unconventional plays uneconomic. Outlook is more positive for natural gas, as the government seeks to increase the share of ga
China Pharmaceuticals and Healthcare Report
BMI View: China will become a leading medical research hub within the Asia Pacific region. This will be largely led by multinational pharmaceutical firms as they seek to tap the large talent pool within the country and develop treatments 'in China, for China'. The local industry, while stil
China Telecommunications Report
BMI View: Operator strategies will continue to chime with the government's directive to drive uptake of wireline broadband and machine-to-machine (M2M) connections. However, this means that even as subscription numbers rise, the prices of basic services will be compressed and operators will derive p
Global and China Lithium Carbonate Industry Report, 2016-2020
Driven by a surge in sales volume of new energy vehicles in China, the upstream material- lithium carbonate was in short supply in the fourth quarter of 2015 with soaring prices. Global lithium carbonate output increased by 12.3% year on year to 202,800 tons in 2015 and is expected to arrive at 244,

Select a Licence type

Custom Research

We are known to provide exact requirements. Try our CUSTOM RESEARCH option and get the exact search result you are searching for.

Contact Us

Postal Address:
808, Real Tech Park, 8th Floor, Sector - 30A, Vashi, Navi Mumbai - 400703 , INDIA .
Telephone: +91 22 27810772, 27810773
Email: info@marketreportsonchina.com
Fax Number: +91 22 27812707

Follow Us On: